Skip to main content

Triple Antibiotic Plus Pain Relief

NDC 83324-036 · Chain Drug Marketing Association Inc.

Generic nameBacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate
Dosage formOINTMENT
RouteTOPICAL
Active ingredient(s)BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE
Strength500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g
Pharmacologic classAminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
Marketing categoryOTC MONOGRAPH DRUG

Packages

83324-036-01 — 1 TUBE in 1 BOX (83324-036-01) / 28.3 g in 1 TUBE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

83107-015 — hydrocortisone acetate and pramoxine hydrochloride, 83107-016 — hydrocortisone acetate and pramoxine hydrochloride, 83107-017 — hydrocortisone acetate and pramoxine hydrochloride, 83107-018 — hydrocortisone acetate and pramoxine hydrochloride, 83107-019 — hydrocortisone acetate and pramoxine hydrochloride, 83107-020 — hydrocortisone acetate and pramoxine hydrochloride, 83107-021 — hydrocortisone acetate and pramoxine hydrochloride, 83107-022 — hydrocortisone acetate and pramoxine hydrochloride, 83165-005 — BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, 83311-335 — PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, 83324-040 — Bacitracin Zinc, 83324-044 — Glycerol, Phenylephine, Pramoxine, Petrolatum, 83324-050 — Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate., 83324-053 — Calamine, Pramoxine HCl, 83324-242 — Calamine Plus Pramoxine HCL, 83324-245 — Pramoxine HCl, Zinc acetate, 83324-264 — Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, 83324-330 — Glycerin, Phenylephine HCI, Pramoxine HCI, Petrolatum, 83807-002 — Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, 83838-155 — Glycerin, Petrolatum, Phenylephrine HCl, Pramoxine HCl, +622 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels